Taking advantage of the latest developments in lentiviral expression systems, Massachusetts Institute of Technology researcher Luk Van Parijs has been using RNA interference to screen hundreds of genes within transgenic animals in order to learn about the genetics of cancer. So far, this approach has been quite successful — data from the work has already been submitted for publication — and now Van Parijs and colleagues have begun to investigate whether they can get similar results for diabetes.